[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer.

导出 OA

翻译打印收藏纠错

第一作者： Fei,Ouyang

第一单位： Department of Gynecology and Obstetrics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, P.R. China.

作者： Fei,Ouyang ^[1] ; Junling,Liu ^[2] ; Meng,Xia ^[1] ; Chuyong,Lin ^[3] ; Xianqlu,Wu ^[3] ; Liping,Ye ^[3] ; Libing,Song ^[3] ; Jun,Li ^[4] ; Jing,Wang ^[1] ; Peng,Guo ^[1] ; Mian,He ^[1]

作者单位： Department of Gynecology and Obstetrics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, P.R. China. ^[1] State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P.R. China. ^[2] State Key Laboratory of Oncology in Southern China, Department of Experimental Research,Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510080, P.R. China. ^[3] Department of biochemistry, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, P.R. China. ^[4]

DOI 10.3892/or.2021.8016

PMID 33882645

发布时间 2021-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Oncology reports

2021年45卷5期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer.

Oncology reports

相似文献

Oncology reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer.

Oncology reports

相似文献

Oncology reports

相关期刊

检索历史清除